Skip to navigation menu Skip to content
Informational Alert
Immunologic Disorders

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) Syndrome

Key Clinical and Laboratory Features

  • Common clinical features: Typical triad is early-onset enteropathy (watery diarrhea, onset typically before 6 months of age), endocrinopathy (Type 1 diabetes or thyroiditis) and dermatitis (eczema, psoriasiform dermatitis, pemphigoid, etc.).
  • Other clinical features: Autoimmune hemolytic anemia (AIHA), idiopathic thrombocytopenic purpura (ITP), autoimmune neutropenia, autoimmune hepatitis, autoimmune nephropathy, etc.
  • Physical exam: Dermatitis (eczema) is common. Sometimes lymphadenopathy and splenomegaly are present.
  • Common laboratory features: Highly elevated IgE in almost all patients. Other immunoglobulin subsets are typically normal. Eosinophilia is common. Markedly decreased or absent FOXP3+ regulatory T cells.

Testing Approach

GENE FOXP3 Gene Sequencing   The gold standard for confirming a diagnosis of IPEX in a patient with suggestive symptoms.
PROTEIN FOXP3/CD25 Protein Flow/TREGFlow   FOXP3 expressing regulatory T cells are absent or markedly decreased in more than 75% of patients with IPEX syndrome. There are however some patients with missense mutations in FOXP3 that express near-normal levels of FOXP3 protein. This test does not provide any information about the regulatory function of the FOXP3 expressing cells.
FUNCTION N/A There are currently no available clinical tests to evaluate FOXP3 protein function.
  • Immunoglobulin levels: IgE typically highly elevated. IgA may also be elevated. IgM/IgG are typically normal.
  • Complete blood count with differential: Eosinophilia is common. Hematocrit and platelets may be low.

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies